Bottle Label 15 mg (71610 0544 30)
Meloxicam Tablet
Product Images NDC 71610-544
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Meloxicam (NDC 71610-544). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Aphena Pharma Solutions (TN)
Chemical Structure (Meloxicam Struct)
Tab1ab (Meloxicam Table 1)
Tab2 (Meloxicam Table2)
This text describes potential symptoms and reactions in various systems of the body, such as allergic reactions, cardiovascular issues, nervous system issues, gastrointestinal problems, heart rate and rhythm issues, hematological disorders, liver and biliary system disorders, dehydration, psychiatric issues, respiratory issues, skin and appendage problems, special senses disturbances, and urinary system disorders. It includes symptoms such as fatigue, weight gain/loss, tremors, vertigo, stomach ulcers, abnormal vision, and more.*
Tab3 (Meloxicam Table3)
Table- 4 (Table 4)
This is a table representing pharmacokinetic parameters for oral 7.5mg and 15mg Meloxicam for steady state and single dose usage in healthy male adults, elderly males, and females with renal or hepatic failure or insufficiency. The table includes information about concentrations, clearance, and volume of distribution. The numbers in the table are derived from various studies and the %CV values represent the coefficient of variation.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
